.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
AstraZeneca
Fuji
US Army
Johnson and Johnson
Chubb
Cerilliant
McKesson
Daiichi Sankyo
Accenture

Generated: November 22, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 009052

« Back to Dashboard
NDA 009052 describes REZIPAS, which is a drug marketed by Bristol Myers Squibb and is included in one NDA. Additional details are available on the REZIPAS profile page.

The generic ingredient in REZIPAS is aminosalicylic acid resin complex. There are fifteen drug master file entries for this compound. Additional details are available on the aminosalicylic acid resin complex profile page.

Summary for 009052

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Formulation / Manufacturing:see details

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:POWDER;ORALStrengthEQ 500MG BASE/GM
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Baxter
Cerilliant
Farmers Insurance
McKesson
Johnson and Johnson
Covington
Queensland Health
Harvard Business School
Federal Trade Commission
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot